EP3478712
And-N3pGlu amýlóíð beta peptíð mótefni og notkun á þeim
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
23.6.2017EP published:
19.7.2023EP application number:
17736841.2
EP translation filed:
21.8.2023Grant published:
15.9.2023EPO information:
European Patent Register
Max expiry date:
22.6.2037Expiry date:
22.6.2026Next due date:
30.6.2026
Title in English:
ANTI-N3PGLU AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOFLanguage of the patent:
English
Timeline
Today
23.6.2017EP application
19.7.2023EP Publication
21.8.2023Translation submitted
15.9.2023Registration published
22.6.2026Expires
Owner
Name:
Eli Lilly and CompanyAddress:
Lilly Corporate Center, Indianapolis, IN 46285, US
Inventor
Name:
DEMATTOS, Ronald BradleyAddress:
Indianapolis Indiana 46206-6288, US
Name:
IRIZARRY, Michael CarlAddress:
Indianapolis Indiana 46206-6288, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201662357579 PDate:
1.7.2016Country:
US
Classification
Categories:
C07K 16/18, A61K 39/395, A61P 25/28
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 23.5.2024
Expires: 22.6.2025
Payer: Árnason Faktor ehf.
Number: 9
Paid: 12.6.2025
Expires: 22.6.2026
Payer: Árnason Faktor ehf.